Annexon, Inc. (ANNX)
4.01
+0.60
(+17.60%)
USD |
NASDAQ |
Oct 19, 16:00
4.11
+0.10
(+2.49%)
After-Hours: 04:26
Annexon Net Income (Quarterly) : -55.35M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.35M |
| March 31, 2026 | -44.14M |
| December 31, 2025 | -48.26M |
| September 30, 2025 | -54.92M |
| June 30, 2025 | -49.16M |
| March 31, 2025 | -54.36M |
| December 31, 2024 | -48.59M |
| September 30, 2024 | -34.82M |
| June 30, 2024 | -29.61M |
| March 31, 2024 | -25.18M |
| December 31, 2023 | -27.89M |
| September 30, 2023 | -32.48M |
| June 30, 2023 | -35.19M |
| March 31, 2023 | -38.68M |
| December 31, 2022 | -34.38M |
| September 30, 2022 | -35.05M |
| Date | Value |
|---|---|
| June 30, 2022 | -37.14M |
| March 31, 2022 | -35.37M |
| December 31, 2021 | -37.37M |
| September 30, 2021 | -35.60M |
| June 30, 2021 | -31.29M |
| March 31, 2021 | -26.06M |
| December 31, 2020 | -23.19M |
| September 30, 2020 | -15.64M |
| June 30, 2020 | -12.24M |
| March 31, 2020 | -12.34M |
| December 31, 2019 | -8.942M |
| September 30, 2019 | -10.19M |
| June 30, 2019 | -9.401M |
| March 31, 2019 | -8.652M |
| December 31, 2018 | -4.661M |
| September 30, 2018 | -4.168M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 55.35M |
| EPS Diluted (Quarterly) | -0.2754 |
| Enterprise Value | 515.57M |
| Earnings Yield | -28.61% |
| Normalized Earnings Yield | -28.61 |